Venue: Stort møterom, Georg Sverdrups hus (University Library), UiO, Blindern, Oslo
08.30 WELCOME, Kåre I. Birkeland
TOPIC I: OMICS IN DIABETES RESEARCH Chair: Lars Christian Stene
08.45 Key note lecture I: MULTI-OMICS IN PRECICTION OF INCIDENT TYPE 2 DIABETES, Nick Wareham MRC, Cambridge, UK
09.30 Invited lecture: OMICS ANALYSES AT THE NORWEGIAN SEQUENCING CENTRE, Gregor Gifillan, OUS node at the Norwegian Sequencing Centre
10.00 ODF-presentation: CAN CHANGES IN INSULIN RESISTANCE AFTER EXERCISE TRAINING BE PREDICTED BY ARTIFICIAL INTELLIGENCE BASED ON LARGE-SCALE SERUM PROTEOMICS?, Sindre Lee-Ødegård
10.15 General discussion
10.30 Coffee break
TOPIC II: TYPE 1 DIABETES AND COMPLICATIONS, Chair: Tore Julsrud Berg
11.00 Key note lecture II: LESSONS FROM THE LARGE NATIONWIDE FINNDIANE STUDY, Per-Henrik Groop, University of Helsinki, Finland
11.45 ODF-presentation: END-STAGE RENAL DISEASE: INCIDENCE AND PREDICTION BY CORONARY HEART DISEASE, AND EDUCATIONAL LEVEL. FOLLOW-UP FROM DIAGNOSIS OF CHILDHOOD-ONSET TYPE 1 DIABETES THROUGHOUT NORWAY 1973-2017, Maryam Saeed
12.00, ODF-presentation: INTESTINAL FATTY ACID BINDING PROTEIN IS ASSOCIATED WITH CORONARY ARTERY DISEASE IN LONG-TERM TYPE 1 DIABETES. THE DIALONG STUDY, Marte Narum
12.15 LUNCH
TOPIC III: DIABETES AND EATING, Chair: Line Wisting
13.15 Key note lecture III: “I HAVEN’T TOLD ANYONE BUT YOU”: ASSESSING AND ADDRESSING BINGE EATING IN PEOPLE WITH TYPE 2 DIABETES, Pil Lindgreen, Steno Research Center, Copenhagen
14.00 ODF-presentation: DIABETES BODY PROJECT: SHORT-TERM EFFECTS OF AN EATING DISORDER PREVENTION PROGRAM FOR YOUNG FEMALES WITH TYPE 1 DIABETES, Severina Haugsvik
14.15 ODF-presentation: DIAMESTER, Anne Marie Aas
14.30 General discussion
14.45 Coffee break
TOPIC IV: PREVENTION OF TYPE 1 DIABETES, Chair: Lars Krogvold
15.00 Key note lecture IV: SCREENING AND PREVENTION OF TYPE 1 DIABETES, Helena Elding Larsson, CRC, Lund University, Malmö, Sweden
15.45 ODF-presentation: Long-term results of the DIVID-intervention study, Ida Maria Mynarek
16.00, ODF-presentations: PLANS FOR A NEW CLINICAL INTERVENTION STUDIES
16.15 COMBINATION OF ANTIVIRAL AND IMMUNOMODULATION THERAPY FOR PREVENTION OF TYPE 1 DIABETES, Knut Dahl-Jørgensen
16.30 DECIDUAL STROMAL CELL THERAPY IN NEW-ONSET TYPE 1 DIABETES: A STRATEGY TO PROTECT AND PRESERVE CELLS, Hanne Scholz
16.45 General discussion
17.00 COFFEE BREAK
17.30 GENERAL ASSEMBLY
18.30 DINNER OR TAPAS